Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
56 participants
INTERVENTIONAL
2025-04-15
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Routine Prescription Feedback and Peer Comparison to Lower Antibiotic Prescriptions in Primary Care
NCT01773824
Community Interventions for Tackling Antimicrobial Resistance in Ghana
NCT07284914
Providing Antibiotic Prescribing Feedback to Primary Care Physicians: The Ontario Program To Improve AntiMicrobial USE
NCT03776383
Impact of a Simple Automated Best Practice Alert (BPA) on Quantity and Quality of In-hospital Antibiotic Use in a Tertiary and Three Secondary Hospitals
NCT07115966
Smartphone App-assisted Short-term Antibiotic Therapy
NCT06126900
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The specific objectives are the following:
Objective 1. Assess the effect of a behavioral intervention targeted to junior physicians on antibiotics prescription rate, including by caste and gender of the patient. A stepped-wedge randomized control trial (RCT) will be conducted among 60 junior physicians in five hospitals (1 government, 2 private teaching, and 2 community) in Nepal. The intervention will be rolled out sequentially across the hospitals and data will be collected from patients (n=3,600) both before and after the intervention. The intervention will consist of three components: (a) a Refresher Training on AMR, (b) a Diagnosis Mandate, and (c) an Individualized Feedback.
Objective 2. Identify barriers to scaling up the intervention beyond the study's site and strategies for their mitigation. After preliminary analysis of the quantitative data, key informant interviews with national- and provincial- level health policy makers (n=5), and in-depth interviews with physicians (n=5) and hospital managers (n=5) will be conducted.
Objective 3. Assess the extent to which physicians prescribe antibiotics correctly. From a subset of patients (n=120, i.e., 2 per physician), more detailed medical information will be collected and analyzed from their outpatient booklet.
This registration is for objective 1. Therefore, only details pertaining to that objective will be provided here.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
CROSSOVER
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
During this phase, physicians do not receive any intervention.
No interventions assigned to this group
Diagnosis Mandate
In this phase, physicians receive a refresher training on AMR and a letter requiring the physicians to specify the diagnosis in their prescription note.
Diagnosis Mandate
The intervention consists of: a) a Refresher Training on AMR, and (b) a Diagnosis Mandate.
Feedback
In this phase, physicians receive a customized feedback letter on their prescription behavior, including antibiotics prescription rate.
Individualized Feedback
Physicians receive a customized feedback on their prescription behavior, including antibiotics prescription rate.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnosis Mandate
The intervention consists of: a) a Refresher Training on AMR, and (b) a Diagnosis Mandate.
Individualized Feedback
Physicians receive a customized feedback on their prescription behavior, including antibiotics prescription rate.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* working at an outpatient clinic in one of the participating hospitals.
* age 18+
* sought care at one of the outpatient clinics in the participating hospitals.
Exclusion Criteria
* working at more than one of the participating hospitals
For patients:
* \<18 years of age
* one of the vulnerable populations (pregnant women, cognitively impaired adults)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Penn State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yubraj Acharya, Ph.D.
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pennsylvania State University
University Park, Pennsylvania, United States
Institute for Social and Environmental Research - Nepal
Bharatpur, Bagmati, Nepal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00025143
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.